文献速递鼻科

使用异丙托溴铵鼻喷雾反应作为脑脊液鼻漏诊断检查中的筛查工具

Using Ipratropium Bromide Nasal Spray Response as a Screening Tool in the Diagnostic Workup of Cerebrospinal Fluid Rhinorrhea.
PubMed 文献 · Laryngoscope · 2023-06-02

前瞻性队列研究纳入单侧清亮稀薄鼻漏患者,均行β-2转铁蛋白检测并处方0.06%异丙托溴铵鼻喷雾。结果显示鼻喷雾反应预测脑脊液鼻漏的敏感度96%、特异度100%,阳性预测值100%、阴性预测值91%。

要点

  • 0.06%异丙托溴铵鼻喷雾反应预测脑脊液鼻漏的曲线下面积未报告,但OR=844.66,p=0.001。
  • 体位性鼻漏加重OR=8.22,p=0.049;体重指数≥30的OR=2.92,p=0.048。
  • 异丙托溴铵鼻喷雾反应筛查脑脊液鼻漏的敏感度96%、特异度100%、阳性预测值100%、阴性预测值91%。

核心结论

  • 在单侧清亮稀薄鼻漏患者中,0.06%异丙托溴铵鼻喷雾反应是排除脑脊液鼻漏的极好筛查工具,应考虑用于脑脊液鼻漏的诊断检查。

研究设计与样本

  • 前瞻性队列研究,所有单侧清亮稀薄鼻漏患者均行鼻液β-2转铁蛋白检测并处方0.06%异丙托溴铵鼻喷雾,最终20例诊断为脑脊液鼻漏,53例为非脑脊液病因。

主要发现

  • 异丙托溴铵鼻喷雾反应预测脑脊液鼻漏的OR=844.66,p=0.001。
  • 体位性鼻漏加重预测脑脊液鼻漏的OR=8.22,p=0.049。
  • 体重指数≥30预测脑脊液鼻漏的OR=2.92,p=0.048。
  • 异丙托溴铵鼻喷雾反应预测脑脊液鼻漏的敏感度96%、特异度100%、阳性预测值100%、阴性预测值91%。

关键数值与推荐

  • 异丙托溴铵鼻喷雾反应预测脑脊液鼻漏的OR=844.66,p=0.001。
  • 体位性鼻漏加重预测脑脊液鼻漏的OR=8.22,p=0.049。
  • 体重指数≥30预测脑脊液鼻漏的OR=2.92,p=0.048。
  • 异丙托溴铵鼻喷雾反应预测脑脊液鼻漏的敏感度96%、特异度100%、阳性预测值100%、阴性预测值91%。

临床怎么用

  • 作者认为,在单侧清亮稀薄鼻漏患者中,0.06%异丙托溴铵鼻喷雾反应是排除脑脊液鼻漏的极好筛查工具,应考虑用于脑脊液鼻漏的诊断检查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Unilateral clear thin rhinorrhea (UCTR) can be concerning for a nasal cerebrospinal fluid (CSF) leak. Beta-2 transferrin electrophoresis has been the gold standard for initial non-invasive confirmatory testing for CSF rhinorrhea, but there can be issues with fluid collection and testing errors. Ipratropium bromide nasal spray (IBNS) is highly effective at reducing rhinitis-related rhinorrhea, and should presumably not resolve CSF rhinorrhea. This study assessed whether different clinical features and IBNS response helped predict presence or absence of CSF rhinorrhea. METHODS: A prospective cohort study was conducted where all patients with UCTR had nasal fluid tested for beta-2 transferrin, and were prescribed 0.06% IBNS. Patients were diagnosed with CSF rhinorrhea or other rhinologic conditions. Clinical variables like IBNS response (rhinorrhea reduction), positional worsening, salty taste, postoperative state, female gender, and body-mass index were assessed for their ability to predict CSF rhinorrhea. Sensitivity, specificity, and predictive values and odds ratios were calculated for all clinical variables. RESULTS: Twenty patients had CSF rhinorrhea, and 53 had non-CSF etiologies. Amongst clinical variables assessed for predicting CSF absence or presence, significant associations were shown for IBNS response (OR = 844.66, p = 0.001), positional rhinorrhea worsening (OR = 8.22, p = 0.049), and body-mass index ≥30 (OR = 2.92, p = 0.048). IBNS response demonstrated 96% sensitivity and 100% specificity, and 100% positive and 91% negative predictive values for predicting CSF rhinorrhea. CONCLUSIONS: In patients with UCTR, 0.06% IBNS response is an excellent screening tool for excluding CSF rhinorrhea, and should be considered in the diagnostic workup of CSF rhinorrhea. LEVEL OF EVIDENCE: 2 Laryngoscope, 134:56-61, 2024.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Nulty P, Mason W, Mackie H, et al. Using Ipratropium Bromide Nasal Spray Response as a Screening Tool in the Diagnostic Workup of Cerebrospinal Fluid Rhinorrhea. Laryngoscope. 2023. PMID: 37265206. doi:10.1002/lary.30801

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。